X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3441) 3441
Book Review (754) 754
Publication (212) 212
Book / eBook (43) 43
Book Chapter (10) 10
Conference Proceeding (10) 10
Magazine Article (9) 9
Dissertation (5) 5
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (3362) 3362
humans (3340) 3340
index medicus (3201) 3201
adult (1864) 1864
cervical cancer (1530) 1530
middle aged (1376) 1376
uterine cervical neoplasms - prevention & control (1194) 1194
cancer (1158) 1158
uterine cervical neoplasms - virology (991) 991
women (978) 978
uterine cervical neoplasms - diagnosis (910) 910
human papillomavirus (860) 860
uterine cervical neoplasms - pathology (854) 854
oncology (810) 810
vaginal smears (765) 765
adolescent (742) 742
aged (709) 709
uterine cervical neoplasms - epidemiology (709) 709
risk factors (706) 706
obstetrics & gynecology (653) 653
papillomavirus infections (608) 608
health aspects (592) 592
diagnosis (581) 581
abridged index medicus (548) 548
young adult (539) 539
papanicolaou test (516) 516
prevention (479) 479
risk (465) 465
prevalence (449) 449
colposcopy (439) 439
cervical intraepithelial neoplasia (435) 435
papillomavirus infections - virology (435) 435
cervical intraepithelial neoplasia - pathology (431) 431
research (427) 427
cervical intraepithelial neoplasia - virology (423) 423
papillomavirus infections - prevention & control (418) 418
papillomavirus infections - complications (397) 397
intraepithelial neoplasia (389) 389
papillomavirus infections - epidemiology (382) 382
papillomavirus infections - diagnosis (360) 360
hpv (355) 355
papillomaviridae - isolation & purification (346) 346
cervical intraepithelial neoplasia - diagnosis (345) 345
mass screening (345) 345
infection (336) 336
papillomaviridae - genetics (331) 331
cytology (323) 323
medical screening (317) 317
public, environmental & occupational health (317) 317
cervix uteri - pathology (307) 307
pathology (297) 297
human-papillomavirus (292) 292
lesions (284) 284
analysis (277) 277
male (272) 272
medicine, general & internal (270) 270
pregnancy (264) 264
neoplasia (261) 261
screening (258) 258
mass screening - methods (257) 257
dysplasia (255) 255
retrospective studies (254) 254
sensitivity and specificity (254) 254
cervix (253) 253
womens health (253) 253
incidence (252) 252
vaccination (252) 252
cervical intraepithelial neoplasia - epidemiology (248) 248
uterine cervix (242) 242
human-papillomavirus infection (233) 233
epidemiology (231) 231
care and treatment (230) 230
cross-sectional studies (228) 228
uterine cervical dysplasia - diagnosis (228) 228
cervical-cancer (225) 225
natural-history (222) 222
obstetrics and gynecology (221) 221
biopsy (217) 217
uterine cervical dysplasia - pathology (217) 217
age factors (214) 214
cervical intraepithelial neoplasia - prevention & control (214) 214
vaccines (214) 214
uterine cervical neoplasms - etiology (211) 211
cervix dysplasia (210) 210
follow-up (208) 208
young-women (208) 208
follow-up studies (207) 207
papillomaviruses (195) 195
uterine cervical neoplasms - therapy (190) 190
mortality (189) 189
research article (187) 187
uterine cervical neoplasms - genetics (184) 184
carcinoma (180) 180
dna (175) 175
papillomaviridae (175) 175
aged, 80 and over (174) 174
infectious diseases (174) 174
papillomavirus infections - pathology (172) 172
dna, viral - analysis (170) 170
genotype (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3345) 3345
French (38) 38
German (37) 37
Polish (23) 23
Spanish (11) 11
Italian (10) 10
Russian (10) 10
Japanese (8) 8
Chinese (5) 5
Norwegian (5) 5
Danish (4) 4
Dutch (4) 4
Portuguese (3) 3
Swedish (3) 3
Bulgarian (2) 2
Czech (2) 2
Korean (2) 2
Bosnian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 10/2014, Volume 111, Issue 9, pp. 1824 - 1830
Background: In Scotland, a national HPV immunisation programme began in 2008 for 12- to 13-year olds, with a catch-up campaign from 2008 to 2011 for those... 
vaccine | cervical intraepithelial neoplasia | human papillomavirus | AUSTRALIA | METAANALYSIS | COVERAGE | PREVALENCE | AWARENESS | HPV-16/18 AS04-ADJUVANTED VACCINE | IMPACT | ONCOLOGY | CROSS-PROTECTIVE EFFICACY | YOUNG-WOMEN | PROGRAM | Cervical Intraepithelial Neoplasia - pathology | Prevalence | Prognosis | Follow-Up Studies | Vaccine Potency | Humans | Uterine Cervical Neoplasms - epidemiology | Vaccination | Uterine Cervical Neoplasms - pathology | Scotland - epidemiology | Uterine Cervical Dysplasia - pathology | National Health Programs | Papillomavirus Infections - pathology | Young Adult | Neoplasm Grading | Uterine Cervical Dysplasia - virology | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Uterine Cervical Dysplasia - epidemiology | Colposcopy | Papillomavirus Vaccines - therapeutic use | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomaviridae - isolation & purification | Uterine Cervical Dysplasia - prevention & control | Cervical Intraepithelial Neoplasia - virology | Mass Screening | Papillomavirus Infections - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Cohort Studies | Index Medicus | Epidemiology
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1732 - 1741
Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to... 
Hematology, Oncology and Palliative Medicine | Papillomavirus vaccines | Human papillomavirus | Vulvar neoplasms | Vaginal neoplasms | Uterine cervical neoplasms | Precancerous conditions | Anus neoplasms | GLOBAL BURDEN | INFECTIONS | Uterine cervical neo-plasms | VACCINE | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | WORLDWIDE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | INVASIVE CERVICAL-CANCER | VULVA | Predictive Value of Tests | Age Distribution | Age Factors | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Young Adult | Papillomaviridae - immunology | Uterine Cervical Dysplasia - virology | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Cervical Neoplasms - diagnosis | Cross-Sectional Studies | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Vulvar Neoplasms - virology | Uterine Cervical Dysplasia - prevention & control | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Anus Neoplasms - diagnosis | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Vulvar Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Aged | Human Papillomavirus DNA Tests | DNA, Viral - genetics | Vaginal Neoplasms - diagnosis | Papillomaviruses | Genetic aspects | Papillomavirus infections | Cervical cancer | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2012, Volume 104, Issue 22, pp. 1712 - 1723
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now licensed in several countries. Furthermore, clinical trials examining the... 
AGED 16-26 YEARS | COST-EFFECTIVENESS | ECONOMIC-EVALUATION | ONCOLOGY | PARTICLE VACCINE | FOLLOW-UP | GENITAL WARTS | NATURAL-HISTORY | NONVACCINE HPV TYPES | CERVICAL INTRAEPITHELIAL NEOPLASIA | DEVELOPED-COUNTRIES | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Condylomata Acuminata - virology | Condylomata Acuminata - epidemiology | Male | Condylomata Acuminata - prevention & control | Incidence | Young Adult | Canada - epidemiology | Uterine Cervical Dysplasia - virology | Adult | Female | Cervical Intraepithelial Neoplasia - epidemiology | Uterine Cervical Dysplasia - epidemiology | Child | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - transmission | Papillomavirus Infections - complications | Sexual Behavior | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Models, Statistical | Uterine Cervical Dysplasia - prevention & control | Cervical Intraepithelial Neoplasia - virology | Mass Screening | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Complications and side effects | Care and treatment | Squamous cell carcinoma | Cervix dysplasia | Vaccines | Research | Health aspects | Papillomavirus infections | Risk factors | Human papillomavirus | Sexual behavior | Clinical trials | Comparative analysis | Epidemiology | Girls | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 438 - 443
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2006, Volume 95, Issue 11, pp. 1459 - 1466
Journal Article
JAMA, ISSN 0098-7484, 05/2002, Volume 287, Issue 18, pp. 2382 - 2390
CONTEXT Every year approximately 2 million US women are diagnosed as having a cervical cytological result of atypical squamous cells of undetermined... 
CYTOLOGIC ABNORMALITIES | MEDICINE, GENERAL & INTERNAL | PAPANICOLAOU SMEAR | RISK-FACTORS | GENITAL HUMAN-PAPILLOMAVIRUS | THINPREP PAP TEST | NATURAL-HISTORY | YOUNG-WOMEN | HUMAN-PAPILLOMAVIRUS INFECTION | CERVICAL INTRAEPITHELIAL NEOPLASIA | GYNECOLOGIC CYTOLOGY | Vaginal Smears - economics | Colposcopy - economics | Health Status Indicators | United States | Humans | Tumor Virus Infections - diagnosis | DNA, Viral - analysis | Mass Screening - methods | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Cervical Intraepithelial Neoplasia - economics | Uterine Cervical Dysplasia - virology | Uterine Cervical Neoplasms - economics | Female | Uterine Cervical Dysplasia - economics | Models, Theoretical | Quality-Adjusted Life Years | Uterine Cervical Neoplasms - diagnosis | Mass Screening - economics | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Papillomaviridae - isolation & purification | Uterine Cervical Dysplasia - prevention & control | Disease Progression | Cervical Intraepithelial Neoplasia - virology | Cost-Benefit Analysis | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Care and treatment | Cervix dysplasia | Viruses | Medical screening | Cervical cancer | Cells | Benefit cost analysis | Index Medicus | Abridged Index Medicus
Journal Article
Dermatologic Therapy, ISSN 1396-0296, 01/2017, Volume 30, Issue 1, pp. np - n/a
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 2015, Volume 34, Issue C, pp. 14 - 19
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2014, Volume 135, Issue 11, pp. 2612 - 2622
This phase II/III, double‐blind, randomized trial assessed the efficacy, immunogenicity and safety of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted... 
human papillomavirus vaccine | China | safety | efficacy | immunogenicity | Efficacy | Human papillomavirus vaccine | Safety | Immunogenicity | CYTOLOGIC ABNORMALITIES | HUMAN-PAPILLOMAVIRUS TYPE-16 | CANCER | CERVICAL INTRAEPITHELIAL NEOPLASIA | QUADRIVALENT VACCINE | ONCOLOGY | PARTICLE VACCINE | DOUBLE-BLIND | POOLED ANALYSIS | INFECTION | YOUNG-WOMEN | Follow-Up Studies | Humans | Uterine Cervical Dysplasia - immunology | Young Adult | Human papillomavirus 16 - isolation & purification | Neoplasm Grading | Uterine Cervical Dysplasia - virology | Polymerase Chain Reaction | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Treatment Outcome | Uterine Cervical Dysplasia - prevention & control | Cervical Intraepithelial Neoplasia - virology | Human papillomavirus 18 - isolation & purification | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | DNA, Viral - genetics | Women | Clinical trials | Vaccines | Health aspects | Papillomavirus infections | Cervical cancer | Human papillomavirus | Immunization | Clinical outcomes | Effectiveness | Abnormalities | Vaccination | Cervix | Randomization | ATP | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Infectious Causes of Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0139062 - e0139062
Objective Costs associated with HPV-related diseases such as cervical dysplasia, cervical cancer, and genital warts have not been evaluated in Sweden. These... 
MANAGEMENT | METAANALYSIS | COUNTRIES | CANCER SCREENING-PROGRAM | MULTIDISCIPLINARY SCIENCES | DYSPLASIA | CERVICAL-CANCER | GENITAL WARTS | SAMPLES | BURDEN | CARE | Uterine Cervical Dysplasia - therapy | Condylomata Acuminata - therapy | Papillomavirus Infections - complications | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use | Humans | Middle Aged | Uterine Cervical Neoplasms - prevention & control | Sweden - epidemiology | Uterine Cervical Dysplasia - prevention & control | Condylomata Acuminata - prevention & control | Papillomavirus Infections - economics | Papillomavirus Infections - therapy | Young Adult | Papillomavirus Infections - prevention & control | Health Care Costs - statistics & numerical data | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - economics | Uterine Cervical Neoplasms - economics | Adult | Condylomata Acuminata - economics | Female | Uterine Cervical Dysplasia - economics | Uterine Cervical Neoplasms - therapy | Prevention | Cervix diseases | Research | Costs | Neurosciences | Disease | Vaccination | Cytology | Medical services | Life assessment | Epidemiology | Human papillomavirus | Mathematical analysis | Age | Immunization | Dysplasia | Colposcopy | Mortality | Gynecology | Management | Cervix | Medical screening | Obstetrics | Diseases | Disease prevention | Medicine | Warts | Screening | Materials information | Hospitals | Cellular biology | Womens health | Biopsy | Cost analysis | Cervical cancer | Cancer | Index Medicus
Journal Article